Daiichi Sankyo

Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging world-class science and technology for purpose “to contribute to the enrichment of quality of life around the world.” Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize Daiichi Sankyo 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.”